Projets financés
Neurovascular damage determines disease pathophysiology in pediatric mild traumatic brain injury: source of new biomarkers – Neu-vasc
Biomarkers of ANTidepressant RESponse : early indicators and novel targets – ANTaRES
The objective of ANTaRES is to suggest strategies towards true precision in the pharmacotherapy of MDD. Making the transition to precision medicine is urgent for patient compliance, health cost and ultimately remission and outcome. For this, it is necessary to identify biomarkers and algorithmic pre
A neurocomputational biomarker assay for schizophrenia based on E/I-balance – IMBALANCE
Metabolic profiling of the gut-brain axis as a new stratification process to improve behavioural disorders: proof of concept in alcohol dependence – GUT2BEHAVE
Multi-level integrative ‘omics to identify biomarkers in a Schizophrenia and other major psychoses – Muliobio
Neuroimaging and Blood Markers as Indicators of Ketamine Efficacy in Treatment Resistant Depression – NeuroMarKet
STROKE RISK PREDICTION IN ATHEROSCLEROSIS MEASURING CIRCULATING COMPLEMENT SYSTEM PROTEINS – STATEMENT
Genomic, epigenetic and proteomic biomarkers in psychosis: a translational approach including high-risk individuals, patients with schizophrenia and animal models – GEPI-BIOPSY
Altered Translation in Autism – ALTRUISM
